Article
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.
The American journal of gastroenterology - 1 May 2006
Rodríguez-Moranta Francisco, Castells Antoni, Andreu Montserrat, Piñol Virgínia, Castellví-Bel Sergi, Alenda Cristina, Llor Xavier, Xicola Rosa M, Jover Rodrigo, Payá Artemio, Bessa Xavier, Balaguer Francesc, Cubiella Joaquin, Argüello Lidia, Morillas Juan Diego, Bujanda Luis
Abstract excerpt
UNLABELLED: Identification of individuals who should undergo hereditary nonpolyposis colorectal cancer (HNPCC) genetic testing is a critical and difficult issue. For this purpose, the National Cancer Institute outlined a set of recommendations, the Bethesda guidelines, which have recently been revised. OBJECTIVE: To compare the clinical performance of original and revised Bethesda guidelines for the detection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
